
Women in midlife and later should not dismiss new leg discomfort as “just aging.” A recent Washington Post report highlighted peripheral artery disease, or PAD, a circulation problem in the legs that is more likely to be overlooked in women and is linked to higher risk of heart attack and stroke. PAD is not only a leg issue; it can be a sign of wider artery disease elsewhere in the body. ([washingtonpost.com](https://www.washingtonpost.com/wellness/2026/09/30/this-leg-condition-overlooked-women-can-raise-heart-attack-stroke-risk/?utm_source=openai))
That matters after 45 because PAD becomes more common with age, and menopause appears to be a transition point when cardiovascular risk can rise. The best-supported message from current sources is practical: persistent leg symptoms deserve attention, especially if they happen during walking or climbing stairs, because early recognition may help reduce complications. ([cdc.gov](https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html?utm_source=openai))
What the report was saying
The Washington Post story focused on a familiar problem in heart and vascular care: women with PAD may be diagnosed later than men, or not recognized at all, even though PAD can progress from leg pain to wounds that heal slowly and, in severe cases, tissue loss. The article’s central point is consistent with professional guidance that women experience real disparities in how peripheral vascular disease is detected and treated. ([washingtonpost.com](https://www.washingtonpost.com/wellness/2026/09/30/this-leg-condition-overlooked-women-can-raise-heart-attack-stroke-risk/?utm_source=openai))
PAD happens when plaque narrows arteries outside the heart, most often in the legs. The CDC says the classic symptom is pain in the legs with physical activity that improves with rest, but many people have no obvious leg pain. The American Heart Association notes that symptoms can be mistaken for arthritis or other musculoskeletal problems, which can delay diagnosis. ([cdc.gov](https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html?utm_source=openai))
Why it matters after 45
For adults 45 and older, PAD deserves attention because it can be a marker of atherosclerosis throughout the body. The CDC says people with PAD are at risk for coronary artery disease and cerebrovascular disease, which can lead to heart attack or stroke. The AHA likewise describes PAD as part of broader vascular disease, not an isolated leg problem. ([cdc.gov](https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html?utm_source=openai))
Menopause adds another layer. A 2023 PubMed review described PAD as an underestimated part of the cardiovascular risk that rises around menopause, and it noted that menopausal hormone therapy may reduce PAD risk only when started early after the final menstrual period; it also emphasized that the effect depends on the clinical context. That does not mean hormone therapy should be used to prevent PAD on its own. It does mean reproductive history can be relevant in a cardiovascular discussion after 45. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37779405/?utm_source=openai))
What the evidence actually shows
The evidence for the heart-and-stroke connection is strong. PAD is a sign of systemic vascular disease, and major medical organizations consistently link it to higher cardiovascular risk. The CDC says untreated PAD can increase the risk of heart attack and stroke, and AHA patient guidance says the same. ([cdc.gov](https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html?utm_source=openai))
Evidence that women are underdiagnosed or undertreated is also substantial, though the reasons are complex. The AHA’s 2025 scientific statement summarized sex-based differences in prevalence, symptoms, diagnosis, treatment, and outcomes. It also said women with PAD are less likely to receive referral to supervised exercise therapy and less likely to receive guideline-directed medical therapy. ([newsroom.heart.org](https://newsroom.heart.org/news/women-with-pvd-often-underdiagnosed-undertreated-highlighting-need-for-more-research?utm_source=openai))
Symptoms can be subtle. Common signs include cramping, aching, heaviness, burning, numbness, or fatigue in the buttocks, hips, thighs, calves, or feet during activity. But the CDC says up to 4 in 10 people with PAD do not have leg pain, which helps explain why the condition can be missed until it is more advanced. ([cdc.gov](https://www.cdc.gov/heart-disease/about/peripheral-arterial-disease.html?utm_source=openai))
The usual first test is the ankle-brachial index, or ABI, which compares blood pressure in the ankles with blood pressure in the arms. AHA guidance says an ABI of 0.90 or lower is used to confirm lower-extremity PAD. ([heart.org](https://www.heart.org/en/health-topics/peripheral-artery-disease/diagnosing-pad?utm_source=openai))
What remains uncertain
Some questions are still open. The degree to which menopause itself directly changes PAD risk is still being studied, and not every study measures women the same way. The 2023 review suggests timing may matter for hormone therapy, but it does not settle how much risk is due to hormonal change versus aging, smoking, diabetes, blood pressure, cholesterol, or other vascular risk factors that often accumulate over time. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37779405/?utm_source=openai))
There is also no single PAD story for all women. The AHA has said women are underrepresented in randomized trials of peripheral vascular disease, which can limit certainty about how well some findings apply across different groups of women. ([professional.heart.org](https://professional.heart.org/en/science-news/sex-differences-in-peripheral-vascular-disease/top-things-to-know?utm_source=openai))
What adults 45+ should discuss with a clinician
If you have leg pain, cramping, numbness, or fatigue that happens with walking and improves with rest, bring it up. The same is true if one leg seems colder, wounds on the feet heal slowly, or you have reduced walking distance without another clear explanation. A clinician may ask about symptoms, check pulses, and consider an ABI test. ([heart.org](https://www.heart.org/en/health-topics/peripheral-artery-disease/diagnosing-pad?utm_source=openai))
It is especially reasonable to mention other vascular risk factors such as smoking history, diabetes, high blood pressure, high cholesterol, kidney disease, or a history of cardiovascular disease. The AHA and CDC both frame PAD prevention and management around vascular risk reduction, not just symptom control. ([heart.org](https://www.heart.org/en/health-topics/peripheral-artery-disease/understand-your-risk-for-pad?utm_source=openai))
Seek prompt medical care if leg pain is severe, suddenly worsens, or comes with a cold, pale, or blue foot, a nonhealing wound, or signs of infection. Those can indicate more urgent circulation problems that should not wait for a routine visit. ([heart.org](https://www.heart.org/en/health-topics/peripheral-artery-disease/symptoms-of-pad?utm_source=openai))
For women in their mid-40s, 50s, 60s, and beyond, the key takeaway is not to panic. It is to recognize that a leg symptom can sometimes be a window into whole-body vascular health. Catching PAD earlier may help clinicians address both leg function and the broader risk of heart attack and stroke. ([washingtonpost.com](https://www.washingtonpost.com/wellness/2026/09/30/this-leg-condition-overlooked-women-can-raise-heart-attack-stroke-risk/?utm_source=openai))
Sources
- The Washington Post: This leg condition that’s overlooked in women can raise heart attack, stroke risk (2026-09-30)
- The Washington Post: This leg condition that’s overlooked in women can raise heart attack, stroke risk (2026-09-30)
- CDC: About Peripheral Arterial Disease (PAD) (2024-01-01)
- American Heart Association: Diagnosing PAD (2026-01-01)
- American Heart Association: Sex Differences in Peripheral Vascular Disease (2025-01-01)
- PubMed: The Effect of Menopause and Menopausal Hormone Therapy on the Risk of Peripheral Artery Disease (2023-10-01)
